ISTA Pharmaceuticals (ISTA) announces that it landed a U.S. patent allowance for Prolensa along...

|By:, SA News Editor

ISTA Pharmaceuticals (ISTA) announces that it landed a U.S. patent allowance for Prolensa along with partner Senju Pharmaceuticals. The firm says it anticipates filing a New Drug Application with the FDA for Prolensa in H1, with a commercial launch expected in early 2013.